General Information
Get notified when ReceptorPharma Inc moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track ReceptorPharma Inc
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Pharmaceutical
About ReceptorPharma Inc
Taxonomy: Alzheimer's disease, drug discovery, pharmaceuticals, genetic research, drug targeting, neurodegenerative diseases, cancer treatment, novel pathway, competitive advantage
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | 1 |
|
01 Jun 2018 |
ReceptorPharma Inc Alternatives & Competitors
Committed to the development and commercialization of new drug therapeutics for unmet needs
Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative diseases.
Our goal is to make Alzheimer's disease a disease of the past.
FAQ About ReceptorPharma Inc
Don't just browse. Track.
Signal Tracker monitors ReceptorPharma Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.